I wish to start by echoing what has been said by so many in paying tribute to the victims of this tragedy, their families and those many hon. Members who have campaigned tirelessly for such a long time to ensure that this public inquiry takes place. I also pay tribute to our Prime Minister who, after so many people have not, has listened to these concerns and has organised this full public inquiry.
As a doctor, I prescribe blood products—and that will be continuing every day—often for people who are not in the position to make decisions for themselves. I prescribe blood for babies who have been born very prematurely and for children who have cancer—people who are not in the position to make these decisions, just like the youngsters with haemophilia and other constituents who have been mentioned.
This is an issue of trust. It is important that when people go into hospital and receive treatment they are able to trust that the risk-benefit decision that is made with them or, if they are very small or very unwell, on their behalf, is made on the basis of all the known facts and all the available information. With the contaminated blood scandal, it appears that that was not the case. Despite the fact that people knew that HIV, hepatitis and hepatitis B were transmissible through blood products, that information was not made available to the people receiving such products. The bloods were not being properly screened, and even when, as I understand it, bloods were being screened elsewhere, these products were being used on people in the UK.